Work

AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies for Select Gastrointestinal Diseases

Year: 2024

Type: article

Source: Gastroenterology

DOI: 10.1053/j.gastro.2024.01.008

Authors: Anne F. Peery, Colleen R. Kelly, Dina Kao, Byron P. Vaughn, Benjamin Lebwohl, Siddharth Singh, Aamer Imdad, Osama Altayar

Institutions: University of North Carolina at Chapel Hill, Brigham and Women's Hospital, Harvard University, University of Alberta, University of Minnesota, Columbia University, University of California San Diego, University of Iowa, Washington University in St. Louis

Language: English

Topic: Clostridium difficile and Clostridium perfringens research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: University of Minnesota, Canadian Institutes of Health Research, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: Risk factors for asymptomatic diverticulosis, Mechanisms of action of lgl1 in lung branching and alveogenesis, LyophilizeD fecal micrObiome traNsfer for primAry closTridioides difficilE infection (DONATE study): a multicenter randomized controlled trial, Fecal Microbiota Transplant National Registry, Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial, A prospective cohort study to determine the role of obesity in diverticulitis

OpenAlex ID: W4391992243

FWCI: 89.68

Cites: 125

Cited by: 299

Related to: 10